The latest DNA base editor represents a notable advancement in gene editing, addressing the critical issue of bystander edits that can compromise patient safety.
This technology has evolved rapidly over the past decade, transitioning from laboratory research to practical applications in patient care, particularly for debilitating and terminal illnesses.
By enhancing precision in gene editing, this new editor not only improves the efficacy of treatments but also reduces the risks associated with unintended genetic modifications.